BioStock: WntResearch on the revised study plan for the NeoFox-study

WntResearch has published unexpected discoveries in the NeoFox study during the fall. In an interview from the BioStock Life Science Summit, the company's CEO Pernilla Sandwall and co-founder Tommy Andersson tells us about the new discoveries with candidate Foxy-5, the updated study plan and the upcoming rights issue.

Watch the full interview about WntResearch at biostock.se:

https://www.biostock.se/en/2022/12/wntresearch-on-the-revised-study-plan-for-the-neofox-study

This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se